Hepatoprotective effects of chlorogenic acid on mice exposed to aflatoxin B1: Modulation of oxidative stress and inflammation

Toxicon. 2023 Aug 1:231:107177. doi: 10.1016/j.toxicon.2023.107177. Epub 2023 Jun 3.

Abstract

Aflatoxin B1 (AFB1) is widely distributed in crops and feeds, and ingestion of AFB1-contaminated crops is harmful to human/animal health. This study was designed to investigate hepatoprotective effects of chlorogenic acid (CGA), due to its excellent antioxidant and anti-inflammatory activities, on mice exposed to AFB1. Male Kunming mice were orally fed with CGA prior to daily AFB1 exposure for 18 consecutive days. The results showed that CGA treatment reduced the serum activity of aspartate aminotransferase, hepatic malondialdehyde content and pro-inflammatory cytokines synthesis, prevented histopathological changes of the liver, increased hepatic glutathione level, catalase activity and IL10 mRNA expression in mice subjected to AFB1. Taken together, CGA exerted the protective effect on AFB1-induced hepatic damage by modulating redox status and inflammation, suggesting that CGA may be a candidate compound for the treatment of aflatoxicosis.

Keywords: Aflatoxin B1; Chlorogenic acid; Inflammation; Liver; Oxidative stress.

MeSH terms

  • Aflatoxin B1* / metabolism
  • Aflatoxin B1* / toxicity
  • Animals
  • Antioxidants / metabolism
  • Antioxidants / pharmacology
  • Chlorogenic Acid* / pharmacology
  • Chlorogenic Acid* / therapeutic use
  • Humans
  • Inflammation / chemically induced
  • Inflammation / drug therapy
  • Inflammation / metabolism
  • Liver
  • Male
  • Mice
  • Oxidative Stress

Substances

  • Aflatoxin B1
  • Chlorogenic Acid
  • Antioxidants

Supplementary concepts

  • Kunming mice